Beacon Pharmaceuticals Ltd. announced earnings results for the third quarter ended March 31, 2021. For the third quarter, the company announced sales was BDT 2,601.174 million compared to BDT 1,374.991 million a year ago. Operating income was BDT 722.764 million compared to BDT 147.542 million a year ago. Net income was BDT 463.465 million compared to BDT 58.671 million a year ago. Basic earnings per share from continuing operations was BDT 2.01 compared to BDT 0.25 a year ago. For the nine months, sales was BDT 6,331.795 million compared to BDT 4,203.252 million a year ago. Operating income was BDT 1,227.339 million compared to BDT 322.793 million a year ago. Net income was BDT 754.830 million compared to BDT 128.039 million a year ago. Basic earnings per share from continuing operations was BDT 3.27 compared to BDT 0.55 a year ago.